Serial Assessment of Immune Status by Circulating CD8+ Effector T Cell Frequencies for Posttransplant Infectious Complications

To clarify the role of CD8+ effector T cells for infectious complications, 92 recipients were classified according to the hierarchical clustering of preoperative CD8+CD45 isoforms: Group I was naive, Group II was effector memory, and Group III was effector (E) T cell-dominant. The posttransplant infection rates progressively increased from 29% in Group I to 64.3% in Group III recipients. The posttransplant immune status was compared with the pretransplant status, based on the measure (% difference) and its graphical form (scatter plot). In Groups I and II, both approaches showed a strong upward deviation from pretransplant status upon posttransplant infection, indicating an enhanced clearance of pathogens. In Group III, in contrast, both approaches showed a clear downward deviation from preoperative status, indicating deficient cytotoxicity. The % E difference and scatter plot can be used as a useful indicator of a posttransplant infectious complication.

[1]  S. Teramukai,et al.  Initial steroid bolus injection promotes vigorous CD8+ alloreactive responses toward early graft acceptance immediately after liver transplantation in humans , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  S. Uemoto,et al.  Cytotoxic T‐cell‐mediated defense against infections in human liver transplant recipients , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  N. Minato,et al.  Classification of human liver transplant recipients by their preoperative CD8+ T cell subpopulation and its relation to outcome , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  D. Adams,et al.  DEMONSTRATION THAT DONOR-SPECIFIC NONRESPONSIVENESS IN HUMAN LIVER ALLOGRAFT RECIPIENTS IS BOTH RARE AND TRANSIENT , 2004, Transplantation.

[5]  D. Kelvin,et al.  Cytokines Regulate the Pattern of Rejection and Susceptibility to Cyclosporine Therapy in Different Mouse Recipient Strains After Cardiac Allografting1 , 2003, The Journal of Immunology.

[6]  E. Wherry,et al.  Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells1 , 2003, The Journal of Immunology.

[7]  E. Wherry,et al.  Heterologous immunity provides a potent barrier to transplantation tolerance. , 2003, The Journal of clinical investigation.

[8]  E. Wherry,et al.  Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment , 2003, Journal of Virology.

[9]  F. Cainelli,et al.  Infections and solid organ transplant rejection: a cause-and-effect relationship? , 2002, The Lancet. Infectious diseases.

[10]  Raymond M. Welsh,et al.  No one is naive: the significance of heterologous T-cell immunity , 2002, Nature Reviews Immunology.

[11]  E. Keeffe,et al.  Liver transplantation: evolving patient selection criteria. , 2001, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[12]  H. Sollinger,et al.  HUMAN LIVER ALLOGRAFT ACCEPTANCE AND THE “TOLERANCE ASSAY”: IN VITRO ANTI-DONOR T CELL ASSAYS SHOW HYPOREACTIVITY TO DONOR CELLS, BUT UNLIKE DTH, FAIL TO DETECT LINKED SUPPRESSION1 , 2001, Transplantation.

[13]  P. Moss,et al.  Memory T Cells Constitute a Subset of the Human CD8+CD45RA+ Pool with Distinct Phenotypic and Migratory Characteristics1 , 2001, The Journal of Immunology.

[14]  M. Suthanthiran,et al.  Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. , 2001, The New England journal of medicine.

[15]  C. Orosz,et al.  Immunobiology of Allograft Rejection in the Absence of IFN-γ: CD8+ Effector Cells Develop Independently of CD4+ Cells and CD40-CD40 Ligand Interactions1 , 2001, The Journal of Immunology.

[16]  R. Somorjai,et al.  Subclinical rejection--a potential surrogate marker for chronic rejection--may be diagnosed by protocol biopsy or urine spectroscopy. , 2000, Annals of transplantation.

[17]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[18]  N. Greenspan,et al.  Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. , 1999, Journal of immunology.

[19]  L. de Leij,et al.  Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activity. , 1998, Transplantation.

[20]  B. Portmann,et al.  Tolerance and latent cellular rejection in long‐term liver transplant recipients , 1998, Hepatology.

[21]  R. Lechler,et al.  Optimizing a limiting dilution culture system for quantifying the frequency of interleukin-2-producing alloreactive T helper lymphocytes. , 1997, Transplantation.

[22]  C. Pitcher,et al.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. , 1997, The Journal of clinical investigation.

[23]  S. Uemoto,et al.  Infectious complications in living related liver transplantation. , 1994, Journal of pediatric surgery.

[24]  T. Mohanakumar,et al.  Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation. , 1993, The Journal of clinical investigation.

[25]  R. Bone.  Let's agree on terminology: Definitions of sepsis , 1991, Critical care medicine.

[26]  C. Orosz,et al.  Human allograft acceptance is associated with immune regulation. , 2000, The Journal of clinical investigation.

[27]  M. Miller,et al.  Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. , 1993, Transplantation.